Despite volatility in the pharmaceutical sector, this firm saw 4 open-market insider buyers .
One of the most potent indicators in 2017 was the "cluster," where multiple executives (e.g., the CEO, CFO, and a Director) bought simultaneously. stocks with heavy insider buying 2017
: Useful for cross-referencing 2017 insider trades against financial statements and analyst estimates. Insider Transactions Data Sets - SEC.gov Despite volatility in the pharmaceutical sector, this firm
: The primary source for official Form 4 filings, though it requires manual searching. Despite volatility in the pharmaceutical sector
Recorded 4 open-market insider buyers during the year, a strong signal of executive confidence in the luxury brand's turnaround.